These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 3874692

  • 21. Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections.
    Nakazawa H, Hashimoto T, Nishiura T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1983 Sep; 24(3):437-9. PubMed ID: 6357078
    [Abstract] [Full Text] [Related]

  • 22. Amoxicillin/clavulanate in urinary tract infection.
    Gasser TC, Larsen EH, Madsen PO.
    Urology; 1987 Jan; 29(1):111-4. PubMed ID: 3541346
    [Abstract] [Full Text] [Related]

  • 23. Comparative study of amoxycillin and amoxycillin/clavulanic acid in lower respiratory infections.
    Mehta AP, Phutane L, Patel MH, Rupwate RU, Kamat SR.
    J Assoc Physicians India; 1991 Mar; 39(3):251-3. PubMed ID: 1880092
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of uncomplicated urinary tract infections. Effectiveness and tolerance of sultamicillin compared with amoxicillin/clavulanic acid].
    Schütz W.
    Fortschr Med; 1990 Jun 20; 108(18):365-8. PubMed ID: 2198211
    [Abstract] [Full Text] [Related]

  • 25. A clinical and bacteriological evaluation of Augmentin: a new broad spectrum antibiotic in general practice.
    Hansrod D, Howalder R, Rozar GJ.
    East Afr Med J; 1983 Nov 20; 60(11):778-82. PubMed ID: 6368188
    [No Abstract] [Full Text] [Related]

  • 26. Augmentin (amoxycillin-clavulanic acid) compared with amoxycillin alone in the treatment of urinary tract infections in the elderly.
    Gallacher G, Erwin L, Scott PJ, Sleigh JD.
    J Infect; 1986 May 20; 12(3):229-33. PubMed ID: 3522749
    [Abstract] [Full Text] [Related]

  • 27. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR, Nichol KA, Nicolle LE, DeCorby M, McCracken M, Mulvey MR, Zhanel GG.
    J Antimicrob Chemother; 2006 Jun 20; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract] [Full Text] [Related]

  • 28. Continuing problems with the use of Augmentin for urinary tract infections.
    Bailey RR.
    N Z Med J; 1995 Nov 10; 108(1011):465. PubMed ID: 8538968
    [No Abstract] [Full Text] [Related]

  • 29. Treatment of uncomplicated gonococcal urethritis in males with two doses of Augmentin, six hours apart.
    Bee LH, Phang T.
    Singapore Med J; 1985 Apr 10; 26(2):147-9. PubMed ID: 3898395
    [No Abstract] [Full Text] [Related]

  • 30. Amoxicillin-clavulanic acid (Augmentin).
    Med Lett Drugs Ther; 1984 Nov 09; 26(674):99-100. PubMed ID: 6387417
    [No Abstract] [Full Text] [Related]

  • 31. Augmentin in acute exacerbations of chronic bronchitis.
    Aigner K, Schindl R, Mittermayer H.
    J Int Med Res; 1984 Nov 09; 12(6):321-6. PubMed ID: 6335111
    [Abstract] [Full Text] [Related]

  • 32. Amoxicillin plus clavulanic acid in the treatment of recurrent urinary tract infections.
    Brumfitt W, Hamilton-Miller JM.
    Antimicrob Agents Chemother; 1984 Feb 09; 25(2):276-8. PubMed ID: 6561953
    [Abstract] [Full Text] [Related]

  • 33. Single dose treatment of gonococcal urethritis with augmentin in Ibadan.
    Osoba AO, Oyelese AO, Ashiru JO, Ekweozor CC, Ochei J.
    Afr J Med Med Sci; 1985 Feb 09; 14(3-4):169-73. PubMed ID: 3004176
    [Abstract] [Full Text] [Related]

  • 34. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A.
    Arch Intern Med; 2008 Sep 22; 168(17):1897-902. PubMed ID: 18809817
    [Abstract] [Full Text] [Related]

  • 35. [Clinical application of beta-lactamase inhibitors on urinary tract infections].
    Ohkawa M.
    Nihon Rinsho; 1986 Dec 22; 44(12):2573-7. PubMed ID: 3029463
    [No Abstract] [Full Text] [Related]

  • 36. New drug therapy: Augmentin.
    Klaus JR, Ross MF, Knodel LC.
    J Pediatr Health Care; 1988 Dec 22; 2(2):113-5. PubMed ID: 3258378
    [No Abstract] [Full Text] [Related]

  • 37. The efficacy of augmentin as a beta-lactam antibiotic in surgical and medical practice.
    Kirei BR, Mhalu FS, Pallangyo PK, Seif SA.
    East Afr Med J; 1987 Jul 22; 64(7):499-503. PubMed ID: 3691365
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy and tolerability of an amoxycillin/clavulanic acid combination in the treatment of common bacterial infections. A general practitioner trial.
    Levenstein JH.
    S Afr Med J; 1982 Jul 28; 62(5 Spec No):16A-20A. PubMed ID: 7046104
    [Abstract] [Full Text] [Related]

  • 39. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
    Livermore DM, Hope R, Mushtaq S, Warner M.
    Clin Microbiol Infect; 2008 Jan 28; 14 Suppl 1():189-93. PubMed ID: 18154546
    [Abstract] [Full Text] [Related]

  • 40. [In vitro and in vivo activity of a combination of clavulanic acid and amoxicillin against Klebsiella pneumoniae producing extended broad-spectrum betalactamase (CTX-1, SHV-3, SHV-4)].
    Migueres ML, Ronco E, Guenounou M, Philippon A.
    Pathol Biol (Paris); 1989 May 28; 37(5):397-401. PubMed ID: 2674869
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.